You are required to be logged in to access the full website
Click here if you have forgotten your username or password
8 May 2026 - Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced on Friday that the European Commission has approved Sotyktu (deucravacitinib), alone or with methotrexate, for adults with active psoriatic arthritis (PsA) who had an in...
8 May 2026 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) and its Japanese partner Eisai Co Ltd (TYO:4523) announced on Friday that the US Food and Drug Administration (FDA) has extended by three months the review of the supplem...
8 May 2026 - South Korean biopharmaceutical company Mezzion Pharma Co Ltd on Thursday announced written feedback from the US Food and Drug Administration (FDA) following a pre-IND Type C Guidance meeting interaction for the development of udenafil in...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe